CN112690380A - 一种椰子汁饮料 - Google Patents
一种椰子汁饮料 Download PDFInfo
- Publication number
- CN112690380A CN112690380A CN201911011851.5A CN201911011851A CN112690380A CN 112690380 A CN112690380 A CN 112690380A CN 201911011851 A CN201911011851 A CN 201911011851A CN 112690380 A CN112690380 A CN 112690380A
- Authority
- CN
- China
- Prior art keywords
- percent
- juice
- beverage
- coconut
- citric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 28
- 235000020415 coconut juice Nutrition 0.000 title claims abstract description 24
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 13
- 241000234314 Zingiber Species 0.000 claims abstract description 10
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 10
- 235000008397 ginger Nutrition 0.000 claims abstract description 10
- 241000934230 Anoectochilus roxburghii Species 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 18
- 241000719836 Anoectochilus formosanus Species 0.000 claims description 12
- 235000005979 Citrus limon Nutrition 0.000 claims description 9
- 244000131522 Citrus pyriformis Species 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 238000004537 pulping Methods 0.000 claims description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 238000009924 canning Methods 0.000 claims description 3
- 235000021551 crystal sugar Nutrition 0.000 claims description 3
- 238000007872 degassing Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 238000009928 pasteurization Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 19
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 3
- 239000012530 fluid Substances 0.000 abstract description 3
- 210000004185 liver Anatomy 0.000 abstract description 3
- 206010011224 Cough Diseases 0.000 abstract description 2
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 2
- 238000001816 cooling Methods 0.000 abstract description 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 210000004072 lung Anatomy 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 208000026435 phlegm Diseases 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 210000000952 spleen Anatomy 0.000 abstract description 2
- 235000020197 coconut milk Nutrition 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000003405 preventing effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000002977 intracellular fluid Anatomy 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 101100117236 Drosophila melanogaster speck gene Proteins 0.000 description 1
- 241001126309 Fasciolopsis Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000000114 Pain Threshold Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 231100000739 chronic poisoning Toxicity 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 210000005265 lung cell Anatomy 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000037040 pain threshold Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000026455 prostate symptom Diseases 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种椰子汁饮料，由以下重量比的原料制备而成：金线莲2.6％，冰糖3％，姜0.1％，椰子汁48.6％，柠檬酸2.5％，VC‑Na0.02％，余量为山泉水。本发明采用植物配方、安全无副作用；具有养肝凉肺、清凉爽口、化痰止咳、生津健脾、养颜护肤、延缓衰老的作用；而且造价低廉，易于被社会接受，适合大规模生产销售。
Description
技术领域
本发明涉及饮料技术领域，具体涉及一种椰子汁饮料。
背景技术
现有技术所生产饮料多是碳酸饮料和功能性饮料，对身体有相对的损害，如可乐等等碳酸饮料对加重前列腺症状、降低体内钙的吸收，影响骨骼生长，即身高的正常发育，还会阻碍铁质的吸收，含有咖啡因会上瘾，会有咖啡因慢性中毒情况出现等等。
如何为社会提供一种既能解渴，又能健康身体、激活人体细胞、增强人体免疫力，同时又能美容养颜的老幼皆宜的饮料产品是当务之急。
发明内容
本发明的目的是提供一种既能解渴，又能强身的椰子汁饮料。
为解决上述技术问题，本发明采用如下技术方案：
本发明提供一种椰子汁饮料，由以下重量比的原料制备而成：金线莲2.6％，冰糖3％，姜0.1％，椰子汁48.6％，柠檬酸2.5％，VC-Na0.02％，余量为山泉水。
本发明还提供了上述椰子汁饮料的制备方法，包括以下步骤：
1)取配方量鲜姜，分选、清洗、粉碎、榨汁备用
2)金线莲取汁：将配方量的新鲜金线莲全草在沸水中烫1分钟取出，放入由柠檬酸和VC-Na组成的护色液中浸泡4小时，温度65℃，然后打浆，并用200目滤网过滤，得金线莲汁，备用；
3)将配方量柠檬外皮用盐搓后清洗干净，切片，预热10分钟，温度65℃，然后打浆，并用200目滤网过滤，得柠檬汁，备用；
4)将姜汁、金线莲汁、柠檬汁、冰糖、椰子汁置入容器中，加入山泉水煮沸5分钟，边搅拌边缓缓加入柠檬酸，在压力20MPa，温度降至70℃时均质，然后立即罐装；
5)脱气：将均质后的配料通过加热进行脱气，加热温度为50-70℃，时长20-30分钟；
6)密封包装：将脱气后的饮料密封包装；
7)将包装后的饮料用巴氏杀菌法进行杀菌，温度控制在60-65℃，保持30分钟。
本发明的有益效果在于：采用植物配方、安全无副作用；具有养肝凉肺、清凉爽口、化痰止咳、生津健脾、养颜护肤、延缓衰老的作用；而且造价低廉，易于被社会接受，适合大规模生产销售。
以下结合本发明中主要成分对有益效果作进一步说明：
金线莲：《全国中草药汇编》上册记载：性平，味甘、淡；
其药理作用记载如下：
1.保肝作用
福建金线莲水提取物具有明显的降低转氨酶、抗肝组织纤维化、稳定肝细胞膜的作用。福建金线莲用于解酒有奇效，且对肝病患者、酗酒、肝机能引起的疲劳、口臭、便秘、失眠都有治疗功效。
2.降糖作用
福建金线莲水体液显著降低四氯化碳、链脲霉素所致糖尿病小鼠的血糖含量。中国民间利用福建金线莲水煎服治疗糖尿病，有很好的疗效。
3.抗炎、抗菌作用
福建金线莲水提物能消除由二甲苯引起的炎症，三种不同不源的福建金线莲(野生、种植、组培)的水煎液均显示有一定的抗炎作用。福建金线莲有抗菌体,防止菌体细胞之繁殖及抗癌的作用,尤其对肺部细胞之组织,具有强化与抗菌的功效。
4.镇静、镇痛作用
福建金线莲能减少小鼠的自发活动；延长小鼠的痛阈时间，降低小鼠醋酸扭体反应的发生率，说明有一定的镇静、镇痛的作用。
5.抗氧化作用
福建金线莲多糖能清除氧自由基及抑制脂质过氧化的作用，是一种天然抗氧化剂。能促进皮肤细胞的循环，能使皮肤有光泽、弹性，防治老化，调节体内分泌功能，有效防治青春痘、雀斑、黑斑及老年斑。
6.抑制肿瘤细胞
福建金线莲提取物能抑制肿瘤细胞的生长，加速并诱导乳癌细胞死亡，阻断癌细胞结构生成。对胃癌患者，配合食用福建金线莲并施与化学疗效有良好效果。另对肺癌等具有较好的辅助治疗作用。
7.降高血压、降血脂、降高尿酸及防脑中风和心脏病
国内中医师临床试验，用于高血压胆固醇、动脉硬化、狭心症的预防与治疗取得良好效果。
椰汁：含有丰富的钾、镁等矿物质，其成分与细胞内液相似，可纠正脱水和电解质紊乱，达到利尿消肿之效；椰肉及椰汁均有杀灭肠道寄生虫的作用，饮其汁可驱除姜片虫和绦虫，用之于临床，不仅疗效可靠，且无毒副作用，是理想的杀虫消疳食品；另外椰汁含糖类、脂肪、蛋白质、生长激素、维生素和大量的人体必需的微量元素，经常饮用，能益人气力，补充细胞内液，扩充血容量，滋润皮肤，具有驻颜美容作用。
具体实施方式
下面将结合本发明实施例中对本发明的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
一种椰子汁饮料，由以下重量比的原料制备而成：金线莲2.6％，冰糖3％，姜0.1％，椰子汁48.6％，柠檬酸2.5％，VC-Na0.02％，余量为山泉水。
椰子汁饮料的制备方法，包括以下步骤：
1)新鲜生姜，分选、清洗、粉碎、榨汁备用；
2)金线莲取汁：将配方量的新鲜金线莲全草在沸水中烫1分钟取出，放入由柠檬酸和VC-Na组成的护色液中浸泡4小时，温度65℃，然后打浆，并用200目滤网过滤，得金线莲汁，备用；
3)将配方量柠檬外皮用盐搓后清洗干净，切片，预热10分钟，温度65℃，然后打浆，并用200目滤网过滤，得柠檬汁，备用；
4)将姜汁、金线莲汁、柠檬汁、冰糖、椰子汁置入容器中，加入山泉水煮沸5分钟，边搅拌边缓缓加入柠檬酸，在压力20MPa，温度降至70℃时均质，然后立即罐装；
5)脱气：将均质后的配料通过加热进行脱气，加热温度为50-70℃，时长20-30分钟；
6)密封包装：将脱气后的饮料密封包装；
7)将包装后的饮料用巴氏杀菌法进行杀菌，温度控制在60-65℃，保持30分钟。
产品感官评价及理化检测：
分别对实施例以及对比例所制得的市售椰子汁饮料进行感官评价，评价结果如下：
表1：椰子汁饮料的感官评价标准
表2本发明实施例所制得的椰子汁饮料与对比例制得的市售椰子汁饮料在口感方面的评价对比结果
| 项目 | 实施例 | 对比例 |
| 口感 | 4.8 | 3.2 |
从表1、表2可以看出，对比例所制得市售椰子汁饮料的口感比较寡淡，且不够清爽。而本发明实施例所制得的椰子汁饮料皆口感醇厚饱满，清爽可口，远优于目前的市售椰子汁饮料。
显然，本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样，倘若本发明的这些修改和变型属于本发明权利要求及其等同技术的范围之内，则本发明也意图包含这些改动和变型在内。
Claims (2)
1.一种椰子汁饮料，其特征在于，由以下重量比的原料制备而成：金线莲2.6％，冰糖3％，姜0.1％，椰子汁48.6％，柠檬酸2.5％，VC-Na0.02％，余量为山泉水。
2.如权利要求1所述的椰子汁饮料的制备方法，其特征在于，包括以下步骤：
1)取配方量鲜姜，分选、清洗、粉碎、榨汁备用；
2)金线莲取汁：将配方量的新鲜金线莲全草在沸水中烫1分钟取出，放入由柠檬酸和VC-Na组成的护色液中浸泡4小时，温度65℃，然后打浆，并用200目滤网过滤，得金线莲汁，备用；
3)将配方量柠檬外皮用盐搓后清洗干净，切片，预热10分钟，温度65℃，然后打浆，并用200目滤网过滤，得柠檬汁，备用；
4)将姜汁、金线莲汁、柠檬汁、冰糖、椰子汁置入容器中，加入山泉水煮沸5分钟，边搅拌边缓缓加入柠檬酸，在压力20MPa，温度降至70℃时均质，然后立即罐装；
5)脱气：将均质后的配料通过加热进行脱气，加热温度为50-70℃，时长20-30分钟；
6)密封包装：将脱气后的饮料密封包装；
7)将包装后的饮料用巴氏杀菌法进行杀菌，温度控制在60-65℃，保持30分钟。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911011851.5A CN112690380A (zh) | 2019-10-23 | 2019-10-23 | 一种椰子汁饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911011851.5A CN112690380A (zh) | 2019-10-23 | 2019-10-23 | 一种椰子汁饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112690380A true CN112690380A (zh) | 2021-04-23 |
Family
ID=75505440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911011851.5A Pending CN112690380A (zh) | 2019-10-23 | 2019-10-23 | 一种椰子汁饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112690380A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114176135A (zh) * | 2021-12-16 | 2022-03-15 | 海南岛屿食品饮料有限公司 | 一种姜汁椰奶植物蛋白饮料及其制备方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11155536A (ja) * | 1997-11-04 | 1999-06-15 | Food & Agricult Org Of The United Nations | 天然飲料 |
| CN103250796A (zh) * | 2013-05-20 | 2013-08-21 | 厦门加晟生物科技有限公司 | 一种金线莲椰奶的制备方法 |
| CN103349314A (zh) * | 2013-03-19 | 2013-10-16 | 华侨大学 | 金线莲丰水梨保健饮料及其制备方法 |
| CN105495214A (zh) * | 2015-12-21 | 2016-04-20 | 武杰 | 一种金线莲草莓汁饮料及其制作方法 |
-
2019
- 2019-10-23 CN CN201911011851.5A patent/CN112690380A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11155536A (ja) * | 1997-11-04 | 1999-06-15 | Food & Agricult Org Of The United Nations | 天然飲料 |
| CN103349314A (zh) * | 2013-03-19 | 2013-10-16 | 华侨大学 | 金线莲丰水梨保健饮料及其制备方法 |
| CN103250796A (zh) * | 2013-05-20 | 2013-08-21 | 厦门加晟生物科技有限公司 | 一种金线莲椰奶的制备方法 |
| CN105495214A (zh) * | 2015-12-21 | 2016-04-20 | 武杰 | 一种金线莲草莓汁饮料及其制作方法 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114176135A (zh) * | 2021-12-16 | 2022-03-15 | 海南岛屿食品饮料有限公司 | 一种姜汁椰奶植物蛋白饮料及其制备方法 |
| CN114176135B (zh) * | 2021-12-16 | 2023-12-01 | 海南岛屿食品饮料有限公司 | 一种姜汁椰奶植物蛋白饮料及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104287013B (zh) | 一种降血脂降血糖功能性保健醋饮料及其生产工艺 | |
| CN101263921B (zh) | 一种橄榄保健饮料的制备方法 | |
| CN101744079B (zh) | 美容保健柠檬茶 | |
| CN103054113B (zh) | 一种具有降血糖功效的复合果蔬汁饮料 | |
| CN102106580A (zh) | 一种醒酒护肝保健饮料 | |
| CN103598382A (zh) | 一种降血糖三苦茶及其制作方法 | |
| CN101828738B (zh) | 防治糖尿病的保健饮料 | |
| CN102366133A (zh) | 营养健康饮料及其制备方法 | |
| CN106398973A (zh) | 一种万寿果酒及其生产方法 | |
| CN110226688A (zh) | 一种桑葚黄精饮品及其制备方法 | |
| CN105029553A (zh) | 一种果汁蛋钙中药保健饮料及其制备方法 | |
| KR101716297B1 (ko) | 생약성분이 함유된 노루궁뎅이버섯 추출 음료 제조방법 및 그 방법으로 제조된 음료 | |
| CN112690380A (zh) | 一种椰子汁饮料 | |
| CN105296288A (zh) | 一种罗汉果柚子果酒 | |
| CN105331477A (zh) | 一种白葡萄酒及其制备方法 | |
| CN103250829A (zh) | 莲子芯茶饮料 | |
| CN102860378A (zh) | 一种降压保健柿子醋茶饮料及其制备方法 | |
| CN106701413A (zh) | 一种黄精山楂酒的酿制方法 | |
| CN107125521A (zh) | 一种改善睡眠的发酵植物饮料及其制备方法 | |
| CN107057910A (zh) | 一种新型保健果酒的制备方法 | |
| CN107384680A (zh) | 一种百香果龙眼果酒及其酿造方法 | |
| CN106479848A (zh) | 一种金花茶山楂酒 | |
| CN113519737A (zh) | 一种解酒护肝的多肽饮品及其制备方法 | |
| CN109266503A (zh) | 一种保健醋及其制备方法 | |
| CN103610163B (zh) | 一种功能性复合枣酪饮料及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210423 |
|
| RJ01 | Rejection of invention patent application after publication |